Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

500 POSTS 0 COMMENTS

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

Psygen Industries Ltd letter to Health Canada re: SAP

The Psilocybin Supply Chain: An Evidence-Based Review

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

Psygen Industries Ltd letter to Health Canada re: SAP

The Psilocybin Supply Chain: An Evidence-Based Review

November 2020 Newsletter

Sept/Oct 2020 Newsletter

July 2020 Newsletter

June 2020 Newsletter

CLINICAL RESEARCH ASSOCIATE

EDITOR PICKS

Martha Hammel and Tasia Poinsatte – Aspen Psychedelic Symposium

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY